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$SDWLHQWZLWKQRQLVFKHPLFFDUGLRP\RSDWK\DQGD\HDUROGSULPDU\SURSK\ODFWLFLPSODQWDEOHFDUGLRYHUWHUGH¿EULO-
lator system (ICD) was admitted after experiencing two ICD-shocks. The interrogation of the device revealed chroni-
cally low R-wave amplitudes leading to intermittent T-wave oversensing and inappropriate shock delivery. During box 
exchange, we could avoid lead revision by intraoperative testing and subsequent reprogramming of the sensing vector 
IURPWUXHWRLQWHJUDWHGELSRODUFRQ¿JXUDWLRQLQWKHQHZJHQHUDWRU7KLVSURJUDPPLQJIHDWXUHLVFXUUHQWO\DYDLODEOHRQO\
in certain ICD models.
$QHPLV]NpPLiVFDUGLRP\RSDWKLiEDQV]HQYHGĘpYHVSULPHUSUR¿ODNWLNXVLQGLNiFLyYDOEHOWHWHWWNDUGLRYHUWHUGH-
¿EULOOiWRUUHQGV]HUUHO,&'HOĘEHWHJNpW,&'VRNNOHDGiViWN|YHWĘHQNHUOWIHOYpWHOUH$NpV]OpNOHNpUGH]pVHVRUiQ
krónikusan alacsony R-hullám-amplitúdók igazolódtak, amelyek intermittáló T-hullám-túlérzékeléshez, majd indokolat-
ODQ VRNNOHDGiVRNKR] YH]HWHWWHN $PĦWpW NH]GHWpQ D] pU]pNHOpVL YHNWRU WHV]WHOpVpW YpJH]WN HO HOĘV]|U DPHO\QHN
VRUiQDYDOyGLELSROiULVUyOLQWHJUiOWELSROiULVpU]pNHOpVUHYiOWiVVDOpVD]~MWHOHSEHQW|UWpQĘEHiOOtWiVVDOD]HOHNWUyGD
UHYt]LyMDHONHUOKHWĘYpYiOW(]DSURJUDPR]iVLOHKHWĘVpJMHOHQOHJFVDNEL]RQ\RV,&'PRGHOOHNEHQpUKHWĘHO
.H\ZRUGV ,&'LPSODQWDEOHFDUGLRYHUWHUGH¿EULOODWRU7ZDYHRYHUVHQVLQJVHQVLQJYHFWRUWUXHELSRODU 
integrated bipolar, extended bipolar
,&'EHOWHWKHWĘNDUGLRYHUWHUGH¿EULOOiWRU7KXOOiPW~OpU]pNHOpVpU]pNHOpVLYHNWRUELSROiULVpU]pNHOpV
integrált bipoláris, kiterjesztett bipoláris
.XOFVV]DYDN
Introduction
Implantable cardioverter defibrillators (ICDs) require 
good quality intracardiac signals for appropriate ar-
rhythmia detection. Low R-wave amplitudes during fol-
low-up of patients with ICDs may lead to delayed detec-
tion of ventricular fibrillation (VF) (1), but also to T-wave 
oversensing with inappropriate ICD shocks (2). Troub-
leshooting of such cases can be challenging and often 
require surgical lead revision as the only solution (2, 3).
Case Report
A 48-year-old male patient with a history of non-
ischemic cardiomyopathy received a primary prophy-
lactic VVI-ICD in 2010 (Device: Medtronic Entrust Es-
cudo D144VRC, Lead: Medtronic 6935 Sprint Quattro 
S, Medtronic Inc., Minneapolis, MN, USA) and a left 
ventricular assist device in 2011 )LJXUH. He was ad-
mitted to the hospital in 2018 after experiencing two 
ICD shocks. Interrogation of the device revealed 405 
non-sustained ventricular tachycardia (nsVT) and 5 
sustained ventricular fibrillation (VF) episodes occurri-
ng in the last three months – two of those were shocked 
by the ICD. Further analysis of the shocked VF episo-
des revealed intermittent T-wave oversensing due to 
chronically low R-wave amplitude as the trigger of inap-
propriate shock delivery )LJXUH . R-wave sensing 
decreased gradually from 13.4 mV to an average of 3-4 
mV in the last two years (last measu rement: 3.4 mV) 
without any relevant change of other lead parameters.
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The patient was scheduled for box replacement (cur-
rent battery voltage=2.64 V, ERI=2.61 V) and a poten-
tial lead revision. Intraoperatively we attempted to ma-
ximize the R-wave amplitude and prevent lead revision 
by testing both true bipolar (tip to ring) and integrated 
bipolar (tip to coil) sensing vectors. This assessment 
revealed that tip to coil sensing resulted R-wave ampli-
tudes >5.0 mV compared to tip to ring sensing (2.1–4.8 
mV). Since some of the newer generation ICDs have 
the option to change the sensing vector, we decided 
to implant such a device (Medtronic Evera S VR, DV-
BC3D1), programming the sensing vector to integrated 
bipolar, without need of further lead revision.
The patient was asymptomatic during the next 12 
months. Consistent with clinical findings, interrogation of 
the device revealed excellent sensing values (last mea-
sured R-wave amplitude: 9.8 mV) at regular follow-ups.
FIGURE 1. Patient’s chest X-ray showing the position of the 
VVI-ICD system and left ventricular assist device in AP view
FIGURE 2. Misclassified VF episode due to intermittent T-wave oversensing leading to inappropriate shock delivery
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Discussion
Implantation of an ICD is still the most effective ther-
apeutic option for the prevention of sudden cardiac 
death (4). However, up to 25% of ICD patients may ex-
perience complications as a result of ventricular over-
sensing, most commonly related to T-waves (5). To 
ensure appropriate detection of ventricular fibrillation 
while avoiding T-wave oversensing, current expert opi-
nion recommends that sinus rhythm R-wave amplitude 
on the ventricular electrogram should exceed 5.0 mV at 
implantation. A retrospective analysis of the EMPIRIC 
(n=900 patients) and WAVE (n=1122 patients) clinical 
WULDOVKRZHYHUVXJJHVWVWKDW5ZDYHVP9FRXOGEH
sufficient (6). Nonetheless, patients with T-wave over-
sensing refractory to reprogramming often require sur-
gical lead revision (2, 3) with all its well-known risks, 
including system infection (7).
Depending on the manufacturer, ICDs are available with 
two different right ventricular lead types and sensing 
configurations, respectively. True bipolar configuration 
records intracardiac signals between the distal tip and a 
proximal ring electrode, whereas the electrical vector of 
an integrated bipolar configuration (also called extend-
ed bipolar) occurs between the tip and the more distal 
coil electrode )LJXUH In spite of the bigger surface 
in the integrated bipolar mode, oversensing of external 
electrical noise or myopotentials can still be avoided.
Which sensing polarity is superior to the other is contro-
versial and probably depends on individual patient-spe-
cific factors. Some studies (8, 9) revealed no significant 
difference between true and integrated bipolar sensing 
polarities regarding R-wave amplitude or detection of 
ventricular fibrillation. In a multicentre retrospective study 
of patients with Brugada syndrome, T-wave oversensing 
was more often reported with true bipolar sensing compa-
red to integrated bipolar programming (10), while Weretka 
et al. demonstrated a higher incidence of T-wave over-
sensing with integrated bipolar leads (5). Currently, Medt-
ronic is the only manufacturer offering ICDs with capability 
of both true and integrated bipolar sensing configurations 
(available in Maximo II or newer models from 2008).
In our patient we could avoid a surgical lead revision by 
implanting an ICD capable of switching sensing pola-
rity. By reprogramming the sensing vector, a stable re-
covery of the R-wave amplitude (from 3.4 mV to 9.8 mV) 
was achieved. Although other programming options to 
handle T-wave oversensing (e.g. T-wave oversensing 
algorithms) are available not only in Medtronic devices, 
our findings endorse the development of ICDs with the 
programming capability to change the sensing vector 
configuration.
Conclusions
In patients with low R-wave amplitudes, surgical lead 
revision could be avoided in some cases by changing 
the sensing vector. Development of this function is en-
dorsed in all commercially available ICDs.
'HFODUDWLRQRILQWHUHVW
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